Working... Menu

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel (NSCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01234038
Recruitment Status : Completed
First Posted : November 4, 2010
Last Update Posted : June 27, 2018
Information provided by (Responsible Party):
Ionis Pharmaceuticals, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2012
  Actual Study Completion Date : January 2013
  Certification/Extension First Submitted : June 21, 2018